| 000 | 01501 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516033924.0 | ||
| 264 | 0 | _c20120111 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-011-1650-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRezai, Keyvan | |
| 245 | 0 | 0 |
_aPharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cDec 2011 |
||
| 300 |
_a1529-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLapatinib |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aUrien, S | |
| 700 | 1 | _aIsambert, N | |
| 700 | 1 | _aRoche, H | |
| 700 | 1 | _aDieras, V | |
| 700 | 1 | _aBerille, J | |
| 700 | 1 | _aBonneterre, J | |
| 700 | 1 | _aBrain, E | |
| 700 | 1 | _aLokiec, F | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 68 _gno. 6 _gp. 1529-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-011-1650-8 _zAvailable from publisher's website |
| 999 |
_c20784828 _d20784828 |
||